By:
On:
In: Alzheimers, Neurological, Seniors, Vitamins / Drugs

MONDAY, Feb. 14, 2022 (HealthDay News) — Viagra-like drugs might do more than rejuvenate sex lives: A new study suggests that medications for erectile dysfunction may also help treat vascular dementia. The medications are designed to increase blood flow to the penis in order to treat erectile dysfunction, so U.K.Continue Reading

By:
On:
In: Alzheimers, Dieting, Mental Health, Neurological, Obesity, Seniors

TUESDAY, Jan. 25, 2022 (HealthDay News) – Older adults who maintain a steady weight as they age are less likely to experience rapid cognitive decline, regardless of how much they weigh to start, new research suggests. “There’s something about maintaining weight and BMI that seems to reflect some health resilience,”Continue Reading

By:
On:
In: Alzheimers, Health Insurance, Mental Health, Neurological, Public Health, Seniors, Vitamins / Drugs

TUESDAY, Jan. 11, 2022 (HealthDay News) — It’s a move that could severely limit the number of people taking the controversial new Alzheimer’s drug Aduhelm: Medicare on Tuesday proposed to only cover the cost of the pricey medication for people enrolled in approved clinical trials. A final decision on coverageContinue Reading

By:
On:
In: Alzheimers, General Health, Health Insurance, Public Health, Seniors, Vitamins / Drugs

MONDAY, Jan. 10, 2022 (HealthDay News) — Medicare has been told to reassess a significant premium increase it had announced that largely stemmed from the expensive new Alzheimer’s drug Aduhelm. U.S. Health and Human Services Secretary Xavier Becerra’s directive, which was announced on Monday, comes shortly after Aduhelm maker BiogenContinue Reading

By:
On:
In: Alzheimers, Health Insurance, Mental Health, Neurological, Public Health, Seniors, Vitamins / Drugs

FRIDAY, Jan. 7, 2022 (HealthDay News) — Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial Alzheimer’s drug Aduhelm. The drug’s benefits are in question and its annual price tag tops $28,000. The U.S. CentersContinue Reading

By:
On:
In: Alzheimers, Doctors and Health Care, Genetics and Genetic Disorders, Neurological

FRIDAY, Dec. 31, 2021 (HealthDay News) — A certain gene mutation known as APOE4 has long been known to raise the risk for Alzheimer’s disease. Now, researchers report it may also predispose people to increased susceptibility to COVID-19 infection and severe symptoms, including small brain bleeds. Researchers in Finland, whereContinue Reading

By:
On:
In: Alzheimers, General Health, Health Insurance, Vitamins / Drugs

MONDAY, Dec. 20, 2021 (HealthDay News) — The maker of the pricey new Alzheimer’s drug Aduhelm (aducanumab) said Monday it will slash the cost of its medication in half, effective Jan. 1, 2022. The move follows widespread criticism of the drug’s original $56,000-a-year price tag. The reduction in the wholesaleContinue Reading

By:
On:
In: Alzheimers, Eye Care / Vision, Health & Technology, Mental Health, Seniors

TUESDAY, Dec. 7, 2021 (HealthDay News) — People who undergo surgery to treat cataracts may have a lower likelihood of developing Alzheimer’s disease, a new study suggests. Of more than 3,000 older adults with the eye disease, those who had surgery were about 30% less likely to be diagnosed withContinue Reading